par de Castro, Gilberto;Puglisi, Fabio;de Azambuja, Evandro 
;El Saghir, Nagi S;Awada, Ahmad
Référence Critical reviews in oncology/hematology, 59, 1, page (40-50)
Publication Publié, 2006-07
;El Saghir, Nagi S;Awada, Ahmad Référence Critical reviews in oncology/hematology, 59, 1, page (40-50)
Publication Publié, 2006-07
Article révisé par les pairs
| Titre: |
|
| Auteur: | de Castro, Gilberto; Puglisi, Fabio; de Azambuja, Evandro; El Saghir, Nagi S; Awada, Ahmad |
| Informations sur la publication: | Critical reviews in oncology/hematology, 59, 1, page (40-50) |
| Statut de publication: | Publié, 2006-07 |
| Sujet CREF: | Sciences bio-médicales et agricoles |
| Mots-clés: | Angiogenesis |
| Antiangiogenesis agents | |
| Bevacizumab | |
| Metronomic chemotherapy | |
| Molecular-target therapy | |
| Sorafenib | |
| Vascular endothelial growth factor | |
| MeSH keywords: | Angiogenesis Inhibitors -- therapeutic use |
| Clinical Trials as Topic | |
| Humans | |
| Neoplasms -- blood supply | |
| Neoplasms -- drug therapy | |
| Neovascularization, Pathologic | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:1040-8428 |
| info:doi/10.1016/j.critrevonc.2006.02.007 | |
| info:pii/S1040-8428(06)00043-6 | |
| info:scp/33745141942 | |
| info:pmid/16600618 |
